Beyond Air, Inc. (NASDAQ:XAIR – Get Free Report) CEO Steven A. Lisi purchased 1,476,626 shares of the business’s stock in a transaction that occurred on Thursday, September 26th. The shares were purchased at an average cost of $0.50 per share, with a total value of $738,313.00. Following the completion of the acquisition, the chief executive officer now directly owns 3,249,411 shares in the company, valued at $1,624,705.50. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink.
Beyond Air Trading Up 15.1 %
Shares of NASDAQ XAIR opened at $0.38 on Friday. Beyond Air, Inc. has a 1-year low of $0.30 and a 1-year high of $2.61. The company has a market cap of $17.64 million, a PE ratio of -0.21 and a beta of -0.11. The company has a current ratio of 2.63, a quick ratio of 2.42 and a debt-to-equity ratio of 0.84. The company has a 50-day moving average of $0.43 and a two-hundred day moving average of $0.90.
Beyond Air (NASDAQ:XAIR – Get Free Report) last announced its earnings results on Tuesday, August 6th. The company reported ($0.27) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.39) by $0.12. Beyond Air had a negative net margin of 3,272.46% and a negative return on equity of 240.15%. The company had revenue of $0.68 million during the quarter, compared to the consensus estimate of $0.72 million. During the same period in the previous year, the firm posted ($0.45) earnings per share. As a group, equities analysts expect that Beyond Air, Inc. will post -1.03 earnings per share for the current fiscal year.
Institutional Investors Weigh In On Beyond Air
Wall Street Analyst Weigh In
Several equities analysts recently issued reports on XAIR shares. Piper Sandler cut their price target on shares of Beyond Air from $3.50 to $1.00 and set an “overweight” rating for the company in a report on Wednesday, August 7th. BTIG Research downgraded shares of Beyond Air from a “buy” rating to a “neutral” rating in a report on Tuesday, June 25th. Roth Capital raised shares of Beyond Air to a “strong-buy” rating in a report on Friday, August 16th. Finally, Roth Mkm reissued a “buy” rating and set a $2.00 price target on shares of Beyond Air in a report on Friday, August 16th. One analyst has rated the stock with a hold rating, three have issued a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat.com, Beyond Air presently has a consensus rating of “Buy” and a consensus price target of $3.67.
Check Out Our Latest Stock Report on XAIR
Beyond Air Company Profile
Beyond Air, Inc operates as a commercial-stage medical device and biopharmaceutical company in the United States. The company engages in the development of LungFit platform, a nitric oxide generator and delivery system. It offers LungFit PH for the treatment of persistent pulmonary hypertension of the newborn.
Further Reading
- Five stocks we like better than Beyond Air
- Stock Trading Terms – Stock Terms Every Investor Needs to Know
- When Is the Best Time to Invest in Mutual Funds?
- Airline Stocks – Top Airline Stocks to Buy Now
- Is NVIDIA Stock in a Correction or Consolidation?
- Earnings Per Share Calculator: How to Calculate EPS
- 3 Oversold Stocks with Big RSI Rebound Potential
Receive News & Ratings for Beyond Air Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Beyond Air and related companies with MarketBeat.com's FREE daily email newsletter.